Skip to main content

letter

. 1994 Feb;35(2):287. doi: 10.1136/gut.35.2.287-a

Oroileal transit of 5-aminosalicylic acid.

L A Christensen, J Fallingborg

PMCID: PMC1374522 PMID: 8307491

287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Christensen L. A., Fallingborg J., Abildgaard K., Jacobsen B. A., Sanchez G., Hansen S. H., Bondesen S., Hvidberg E. F., Rasmussen S. N. Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in man. Aliment Pharmacol Ther. 1990 Oct;4(5):523–533. doi: 10.1111/j.1365-2036.1990.tb00499.x. [DOI] [PubMed] [Google Scholar]
Goebell H., Klotz U., Nehlsen B., Layer P. Oroileal transit of slow release 5-aminosalicylic acid. Gut. 1993 May;34(5):669–675. doi: 10.1136/gut.34.5.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
Klotz U., Maier K. E., Fischer C., Bauer K. H. A new slow-release form of 5-aminosalicylic acid for the oral treatment of inflammatory bowel disease. Biopharmaceutic and clinical pharmacokinetic characteristics. Arzneimittelforschung. 1985;35(3):636–639. [PubMed] [Google Scholar]

ACTIONS

RESOURCES